🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
No prospective randomized trials have evaluated the most efficacious dose o...
Status
Completed
Location
Dartmouth Hitchcock Medical Center
Start Date
2013-12
Trial ID
NCT02139280
Treatments Being Tested
This is a treatment guideline to allow routine clinical data to be collecte...
Status
Terminated
Location
Masonic Cancer Center, University of Minnesota
Start Date
2013-01
Trial ID
NCT01685411
This is a phase I, prospective clinical trial studying the safety and feasi...
Status
Recruiting
Location
St. Jude Children's Research Hospital
Start Date
2025-09-25
Trial ID
NCT07052370
Background: The mainstay of therapy for newly diagnosed multiple myeloma p...
Status
Completed
Location
National Institutes of Health Clinical Center, 9000 Rockville Pike
Start Date
2001-02-08
Trial ID
NCT00006184
The goal of this clinical research study is to learn if it is possible to c...
Status
Completed
Location
University of Texas MD Anderson Cancer Center
Start Date
2011-08-22
Trial ID
NCT01329900
Treatments Being Tested
ASSIST I was the first randomized trial in patients with scleroderma to not...
Status
Terminated
Location
Northwestern University
Start Date
2011-09-15
Trial ID
NCT01445821
Treatments Being Tested
Patients have severe beta-thalassemia or one of the thalassemia variants. T...
Status
Terminated
Location
Texas Children's Hospital
Start Date
2004-02
Trial ID
NCT00578292
Treatments Being Tested
RATIONALE: Giving chemotherapy, natural killer cells, aldesleukin, and tota...
Status
Terminated
Location
Masonic Cancer Center at University of Minnesota
Start Date
2006-02
Trial ID
NCT00354172
Primary Objective: 1\. To determine the maximally tolerated dose of anti-t...
Status
Terminated
Location
U.T.M.D. Anderson Cancer Center
Start Date
2007-05
Trial ID
NCT00473551
This study will be a single-center treatment protocol, designed to validate...
Status
Completed
Location
Wilmot Cancer Institute
Start Date
2015-10
Trial ID
NCT02660281